Insulin-mediated 'pseudoacromegaly'

Hormones

Volumn 10, Issue 2, 2011, Pages 159-161

  Sam, Amir H ^a   Tan, Tricia ^a   Meeran, Karim ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Colonic polyp; Growth hormone; Insulin resistance; Insulin like growth factor I(IGF I); Phosphatidylinositol 3 kinase; Pseudoacromegaly

Indexed keywords

GLIBENCLAMIDE; GROWTH HORMONE; HUMAN INSULIN; METFORMIN; SOMATOMEDIN C; HUMAN GROWTH HORMONE; INSULIN;

ACANTHOSIS NIGRICANS; ACROMEGALY; ADULT; ARTICLE; BODY MASS; CASE REPORT; CLINICAL EXAMINATION; COARSE FACE; COLON POLYP; CONTINUOUS INFUSION; FEMALE; HORMONE DETERMINATION; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PSEUDOACROMEGALY; SIGNAL TRANSDUCTION; BLOOD; METABOLISM; MIDDLE AGED;

ACROMEGALY; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED;

EID: 79959248640     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1306     Document Type: Article

References (44)

1. Volzke H, Nauck M, Rettig R, et al, 2009 Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample. Eur J Endocrinol 161: 705-713.
2. Trainer PJ, 2002 Editorial: acromegaly-consensus, what consensus? J Clin Endocrinol Metab 87: 3534-3536.
3. Yaqub A, Yaqub N, 2008 Insulin-mediated pseudoacromegaly: a case report and review of the literature. W V Med J 104: 12-15.
4. Lee YH, White MF, 2004 Insulin receptor substrate proteins and diabetes. Arch Pharm Res 27: 361-370.
5. King GL, Rechler MM, Kahn CR, 1982 Interactions between the receptors for insulin and the insulin-like growth factors on adipocytes. J Biol Chem 257: 10001-10006.
6. Moxham CP, Duronio V, Jacobs S, 1989 Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. J Biol Chem 264: 13238-13244.
7. Bailyes EM, Nave BT, Soos MA, Orr SR, Hayward AC, Siddle K, 1997 Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochem J 327: 209-215.
8. Samani AA, Yakar S, LeRoith D, Brodt P, 2007 The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28: 20-47.
9. Slaaby R, Schaffer L, Lautrup-Larsen I, et al, 2006 Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant. J Biol Chem 281: 25869-25874.
10. Sachdev D, Yee D, 2007 Disrupting insulin-like growth factor signaling as a potential cancer therapy. Mol Cancer Ther 6: 1-12.
11. Flier JS, Moller DE, Moses AC, et al, 1993 Insulinmediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance. J Clin Endocrinol Metab 76: 1533-1541.
12. Kumar S, Durrington PN, O'Rahilly S, et al, 1996 Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly. J Clin Endocrinol Metab 81: 3465-3468.
13. Dib K, Whitehead JP, Humphreys PJ, et al, 1998 Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly. A disorder characterized by selective postreceptor insulin resistance. J Clin Invest 101: 1111-1120.
14. Kausch C, Bergemann C, Hamann A, Matthaei S, 1999 Insulin-mediated pseudoacromegaly in a patient with severe insulin resistance: association of defective insulin-stimulated glucose transport with impaired phosphatidylinositol 3-kinase activity in fibroblasts. Exp Clin Endocrinol Diabetes 107: 148-154.
15. Fukunaga Y, Minamikawa J, Inoue D, Koshiyama H, Fujisawa I, 1997 Pseudoacromegaly and hyperinsulinemia: a possibility of premature atherosclerosis? J Clin Endocrinol Metab 82: 3515-3516.
16. Clarke JF, Young PW, Yonezawa K, Kasuga M, Holman GD, 1994 Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem J 300: 631-635.
17. Shepherd PR, Nave BT, Siddle K, 1995 Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase. Biochem J 305: 25-28.
18. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR, 1994 Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14: 4902-4911.
19. Hara K, Yonezawa K, Sakaue H, et al, 1994 1-Phosphatidylinositol 3-kinase activity is required for insulinstimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci U S A 91: 7415-7419.
20. Low L, Chernausek SD, Sperling MA, 1989 Acromegaloid patients with type A insulin resistance: parallel defects in insulin and insulin-like growth factor-I receptors and biological responses in cultured fibroblasts. J Clin Endocrinol Metab 69: 329-337.
21. Rosenthal JW, Kloepfer HW, 1962 An acromegaloid, cutis verticis gyrata, corneal leukoma syndrome. A new medical entity. Arch Ophthalmol 68: 722-726.
22. Kozlova SI, Altshuler BA, Kravchenko VL, 1983 Selflimited autosomal recessive syndrome of skin ulceration, arthroosteolysis with pseudoacromegaly, keratitis, and oligodontia in a Kirghizian family. Am J Med Genet 15: 205-210.
23. Hughes HE, McAlpine PJ, Cox DW, Philipps S, 1985 An autosomal dominant syndrome with 'acromegaloid' features and thickened oral mucosa. J Med Genet 22: 119-125.
24. Dallapiccola B, Zelante L, Accadia L, Mingarelli R, 1992 Acromegaloid facial appearance (AFA) syndrome: report of a second family. J Med Genet 29: 419-422.
25. Irvine AD, Dolan OM, Hadden DR, Stewart FJ, Bingham EA, Nevin NC, 1996 An autosomal dominant syndrome of acromegaloid facial appearance and generalized hypertrichosis terminalis. J Med Genet 33: 972-974.
26. Farah S, Farag T, Sabry MA, et al, 1998 Cutis vertices gyrata-mental deficiency syndrome: report of a case with unusual neuroradiological findings. Clin Dysmorphol 7: 131-134.
27. Nguyen KH, Marks JG, Jr, 2003 Pseudoacromegaly induced by the long-term use of minoxidil. J Am Acad Dermatol 48: 962-965.
28. Stratakis CA, Turner ML, Lafferty A, et al, 2001 A syndrome of overgrowth and acromegaloidism with normal growth hormone secretion is associated with chromosome 11 pericentric inversion. J Med Genet 38: 338-343.
29. Rimoin DL, 1965 Pachydermoperiostosis (idiopathic clubbing and periostosis): Genetic and physiologic considerations. N Engl J Med 272: 923-931.
30. Harbison JB, Nice CM, Jr, 1971 Familial pachydermoperiostosis presenting as an acromegaly-like syndrome. Am J Roentgenol Radium Ther Nucl Med 112: 532-536.
31. Hedayati H, Barmada R, Skosey JL, 1980 Aug; Acrolysis in pachydermoperiostosis. Primary or idiopathic hypertrophic osteoarthropathy. Arch Intern Med 140: 1087-1088.
32. Delhougne B, Deneux C, Abs R, et al, 1995 The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients. J Clin Endocrinol Metab 80: 3223-3226.
33. Fukuda I, Hizuka N, Murakami Y, et al, 2001 Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women's Medical University. Intern Med 40: 987-992.
34. Terzolo M, Reimondo G, Gasperi M, et al, 2005 Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy. J Clin Endocrinol Metab 90: 84-90.
35. Bogazzi F, Cosci C, Sardella C, 2006 Identification of acromegalic patients at risk of developing colonic adenomas. J Clin Endocrinol Metab 91: 1351-1356.
36. Renehan AG, Bhaskar P, Painter JE, et al, 2000 The prevalence and characteristics of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 85: 3417-3424.
37. Giovannucci E, 1995 Insulin and colon cancer. Cancer Causes Control 6: 164-179.
38. Koenuma M, Yamori T, Tsuruo T, 1989 Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res 80: 51-58.
39. Watkins LF, Lewis LR, Levine AE, 1990 Characterization of the synergistic effect of insulin and transferring and the regulation of their receptors on a human colon carcinoma cell line. Int J Cancer 45: 372-375.
40. Schoen RE, Tangen CM, Kuller LH, et al, 1999 Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 91: 1147-1154.
41. Kaaks R, Toniolo P, Akhmedkhanov A, et al, 2000 Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92: 1592-1600.
42. Moschos SJ, Mantzoros CS, 2002 The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63: 317-332.
43. Sandhu MS, Dunger DB, Giovannucci EL, 2002 Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 94: 972-980.
44. Banskota NK, Taub R, Zellner K, King GL, 1989 Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol Endocrinol 3: 1183-1190.